We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

GenVault Corporation Launches GenTegra™ DNA

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

GenVault Corporation has announced the launch of a new product, GenTegra™ DNA. GenTegra DNA is a proprietary inorganic matrix with built-in oxidative protection and antimicrobial activity for dry, room temperature transport and storage of purified DNA.

GenTegra DNA is provided in ready to use aliquots, and purified DNA dried within GenTegra DNA is simply and fully resolubilized with water for direct downstream molecular analysis.

"GenVault's goal is to provide solutions that enable efficiency in biosample management for genomic-based medicine and research. GenTegra DNA is the first of GenVault's next generation of core innovative technologies that will include a broad range of sample types," said David Wellis, Ph.D., CEO of GenVault.

Maintaining DNA integrity as well as simplifying laboratory workflows is no longer a concern with long term storage at room temperature. GenTegra™ DNA ensures sample stability and is compatible with the most demanding molecular assays.

GenTegra along with the full suite of GenVault products provide smart, environmentally and financially sustainable solutions which complement and enhance existing cryostorage systems.